These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 15781134)
1. The fd phage and a peptide derived from its p8 coat protein interact with the HIV-1 Tat-NLS and inhibit its biological functions. Krichevsky A; Rusnati M; Bugatti A; Waigmann E; Shohat S; Loyter A Antiviral Res; 2005 Apr; 66(1):67-78. PubMed ID: 15781134 [TBL] [Abstract][Full Text] [Related]
2. BSA conjugates bearing multiple copies of the basic domain of HIV-1 Tat: Prototype for the development of multitarget inhibitors of extracellular Tat. Bugatti A; Chiodelli P; Rosenbluh J; Loyter A; Rusnati M Antiviral Res; 2010 Jul; 87(1):30-9. PubMed ID: 20398703 [TBL] [Abstract][Full Text] [Related]
3. Identification of a nuclear transport inhibitory signal (NTIS) in the basic domain of HIV-1 Vif protein. Friedler A; Zakai N; Karni O; Friedler D; Gilon C; Loyter A J Mol Biol; 1999 Jun; 289(3):431-7. PubMed ID: 10356319 [TBL] [Abstract][Full Text] [Related]
4. A selection system to study protein-RNA interactions: functional display of HIV-1 Tat protein on filamentous bacteriophage M13. Hoffmann S; Willbold D Biochem Biophys Res Commun; 1997 Jun; 235(3):806-11. PubMed ID: 9207243 [TBL] [Abstract][Full Text] [Related]
5. Backbone cyclic peptide, which mimics the nuclear localization signal of human immunodeficiency virus type 1 matrix protein, inhibits nuclear import and virus production in nondividing cells. Friedler A; Zakai N; Karni O; Broder YC; Baraz L; Kotler M; Loyter A; Gilon C Biochemistry; 1998 Apr; 37(16):5616-22. PubMed ID: 9548947 [TBL] [Abstract][Full Text] [Related]
6. A synthetic peptide bearing the HIV-1 integrase 161-173 amino acid residues mediates active nuclear import and binding to importin alpha: characterization of a functional nuclear localization signal. Armon-Omer A; Graessmann A; Loyter A J Mol Biol; 2004 Mar; 336(5):1117-28. PubMed ID: 15037073 [TBL] [Abstract][Full Text] [Related]
7. HIV TAT basic peptide is not a high-affinity ligand for VEGF receptor 2. Rubio Demirovic A; Canadi J; Weiglhofer W; Scheidegger P; Jaussi R; Kurt BH Biol Chem; 2003; 384(10-11):1435-41. PubMed ID: 14669986 [TBL] [Abstract][Full Text] [Related]
8. Development of a functional backbone cyclic mimetic of the HIV-1 Tat arginine-rich motif. Friedler A; Friedler D; Luedtke NW; Tor Y; Loyter A; Gilon C J Biol Chem; 2000 Aug; 275(31):23783-9. PubMed ID: 10764789 [TBL] [Abstract][Full Text] [Related]
9. The perlecan heparan sulfate proteoglycan mediates cellular uptake of HIV-1 Tat through a pathway responsible for biological activity. Argyris EG; Kulkosky J; Meyer ME; Xu Y; Mukhtar M; Pomerantz RJ; Williams KJ Virology; 2004 Dec; 330(2):481-6. PubMed ID: 15567441 [TBL] [Abstract][Full Text] [Related]
10. Heparin binding by the HIV-1 tat protein transduction domain. Hakansson S; Jacobs A; Caffrey M Protein Sci; 2001 Oct; 10(10):2138-9. PubMed ID: 11567105 [TBL] [Abstract][Full Text] [Related]
11. Targeting of HIV-1 Tat traffic and function by transduction-competent single chain antibodies. Theisen DM; Pongratz C; Wiegmann K; Rivero F; Krut O; Krönke M Vaccine; 2006 Apr; 24(16):3127-36. PubMed ID: 16497417 [TBL] [Abstract][Full Text] [Related]
12. The cationic cell-penetrating peptide CPP(TAT) derived from the HIV-1 protein TAT is rapidly transported into living fibroblasts: optical, biophysical, and metabolic evidence. Ziegler A; Nervi P; Dürrenberger M; Seelig J Biochemistry; 2005 Jan; 44(1):138-48. PubMed ID: 15628854 [TBL] [Abstract][Full Text] [Related]
13. Antibodies against a multiple-peptide conjugate comprising chemically modified human immunodeficiency virus type-1 functional Tat peptides inhibit infection. Devadas K; Boykins RA; Hewlett IK; Wood OL; Clouse KA; Yamada KM; Dhawan S Peptides; 2007 Mar; 28(3):496-504. PubMed ID: 17188401 [TBL] [Abstract][Full Text] [Related]
14. Increased cellular uptake of the human immunodeficiency virus-1 Tat protein after modification with biotin. Chen LL; Frankel AD; Harder JL; Fawell S; Barsoum J; Pepinsky B Anal Biochem; 1995 May; 227(1):168-75. PubMed ID: 7668378 [TBL] [Abstract][Full Text] [Related]
15. HIV-1 Tat peptide immunoconjugates differentially sensitize breast cancer cells to selected antiproliferative agents that induce the cyclin-dependent kinase inhibitor p21WAF-1/CIP-1. Hu M; Wang J; Chen P; Reilly RM Bioconjug Chem; 2006; 17(5):1280-7. PubMed ID: 16984139 [TBL] [Abstract][Full Text] [Related]
16. The HIV-1 Tat nuclear localization sequence confers novel nuclear import properties. Efthymiadis A; Briggs LJ; Jans DA J Biol Chem; 1998 Jan; 273(3):1623-8. PubMed ID: 9430704 [TBL] [Abstract][Full Text] [Related]
17. Furin cleavage of the HIV-1 Tat protein. Tikhonov I; Ruckwardt TJ; Berg S; Hatfield GS; David Pauza C FEBS Lett; 2004 May; 565(1-3):89-92. PubMed ID: 15135058 [TBL] [Abstract][Full Text] [Related]
18. Structural and dynamic properties of the HIV-1 tat transduction domain in the free and heparin-bound states. Hakansson S; Caffrey M Biochemistry; 2003 Aug; 42(30):8999-9006. PubMed ID: 12885232 [TBL] [Abstract][Full Text] [Related]
19. Potent inhibition of HIV-1 gene expression and TAT-mediated apoptosis in human T cells by novel mono- and multitarget anti-TAT/Rev/Env ribozymes and a general purpose RNA-cleaving DNA-enzyme. Unwalla H; Chakraborti S; Sood V; Gupta N; Banerjea AC Antiviral Res; 2006 Nov; 72(2):134-44. PubMed ID: 16790281 [TBL] [Abstract][Full Text] [Related]
20. Protein/peptide transduction domains: potential to deliver large DNA molecules into cells. Snyder EL; Dowdy SF Curr Opin Mol Ther; 2001 Apr; 3(2):147-52. PubMed ID: 11338927 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]